1. Home
  2. ZVIA vs CABA Comparison

ZVIA vs CABA Comparison

Compare ZVIA & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVIA
  • CABA
  • Stock Information
  • Founded
  • ZVIA 2007
  • CABA 2017
  • Country
  • ZVIA United States
  • CABA United States
  • Employees
  • ZVIA N/A
  • CABA N/A
  • Industry
  • ZVIA Beverages (Production/Distribution)
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZVIA Consumer Staples
  • CABA Health Care
  • Exchange
  • ZVIA Nasdaq
  • CABA Nasdaq
  • Market Cap
  • ZVIA 142.5M
  • CABA 118.8M
  • IPO Year
  • ZVIA 2021
  • CABA 2019
  • Fundamental
  • Price
  • ZVIA $2.66
  • CABA $1.19
  • Analyst Decision
  • ZVIA Hold
  • CABA Strong Buy
  • Analyst Count
  • ZVIA 3
  • CABA 8
  • Target Price
  • ZVIA $2.58
  • CABA $21.00
  • AVG Volume (30 Days)
  • ZVIA 603.9K
  • CABA 639.2K
  • Earning Date
  • ZVIA 05-07-2025
  • CABA 05-19-2025
  • Dividend Yield
  • ZVIA N/A
  • CABA N/A
  • EPS Growth
  • ZVIA N/A
  • CABA N/A
  • EPS
  • ZVIA N/A
  • CABA N/A
  • Revenue
  • ZVIA $154,273,000.00
  • CABA N/A
  • Revenue This Year
  • ZVIA $5.70
  • CABA N/A
  • Revenue Next Year
  • ZVIA $7.10
  • CABA N/A
  • P/E Ratio
  • ZVIA N/A
  • CABA N/A
  • Revenue Growth
  • ZVIA N/A
  • CABA N/A
  • 52 Week Low
  • ZVIA $0.62
  • CABA $0.99
  • 52 Week High
  • ZVIA $4.99
  • CABA $13.50
  • Technical
  • Relative Strength Index (RSI)
  • ZVIA 57.74
  • CABA 43.45
  • Support Level
  • ZVIA $1.97
  • CABA $1.11
  • Resistance Level
  • ZVIA $3.20
  • CABA $1.41
  • Average True Range (ATR)
  • ZVIA 0.22
  • CABA 0.11
  • MACD
  • ZVIA 0.05
  • CABA 0.01
  • Stochastic Oscillator
  • ZVIA 55.69
  • CABA 26.67

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: